Please wait
0000818686TEVA PHARMACEUTICAL INDUSTRIES LTDS-3424B5falsefalsefalseDebtDebtDebtEUR1,000,000,000 4.125% Senior Notes due 2031truetruetrue0EX-FILING FEES333-284770 0000818686 2025-05-20 2025-05-20 0000818686 1 2025-05-20 2025-05-20 0000818686 2 2025-05-20 2025-05-20 0000818686 3 2025-05-20 2025-05-20 iso4217:USD xbrli:shares xbrli:pure
Exhibit 107
CALCULATION OF THE REGISTRATION FEE
 
Title of Each Class
of Securities
to be Registered
   
Amount to be
Registered
   
Proposed
Maximum
Offering Price
per Security
   
Proposed
Maximum
Aggregate
Offering Price
   
Amount of
Registration
Fee
€1,000,000,000 4.125% Senior Notes due 2031
    $1,130,000,000    99.349%    $1,122,643,700    $171,876.75
(1)
$500,000,000 6.000% Senior Notes due 2032
    $500,000,000    99.256%    $496,280,000    $75,980.47
(2)
$700,000,000 5.750% Senior Notes due 2030
    $700,000,000    99.418%    $695,926,000    $106,546.27
(2)
Total
    $2,330,000,000
(3)
    N/A    $2,314,849,700
(3)
    $354,403.49
(3)
 
(1)
Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based upon the euro/dollar rate of exchange of €1/$1.13 as of May 20, 2025, as reported by Bloomberg.
(2)
Calculated in accordance with Rule 457(r) under the Securities Act.
(3)
Calculated based upon the euro/dollar rate of exchange of €1/$1.13 as of May 20, 2023, as reported by Bloomberg.